Estrogen Receptor Beta Genetic Variants and Combined Oral Contraceptive Use as Relates to the Risk of Hypertension in Chinese Women

Archives of Medical Research

Volumn 41, Issue 8, 2010, Pages 599-605

  Chen, Cheng ^a   Li, Ying ^b,c   Chen, Feng ^d   Pan, Hongxin ^a   Shen, Hongbing ^d   Sun, Zhiming ^c   Wu, Yulin ^c   Zhou, Jian ^c   Ba, Lei ^c   Zhao, Jinna ^c  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NPFPC Contraceptives Adverse Reaction Monitoring Center   (China)

^c Jiangsu Research Centre for Reproductive Health in Humans   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen receptor beta; Hypertension; Oral contraceptives; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR BETA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; OCCUPATION; ORAL CONTRACEPTION; POPULATION RESEARCH; RESIDENTIAL AREA; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 78650742727     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.10.011     Document Type: Article

References (25)

1. Hodges Y.K., Tung L., Yan X.D., et al. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2000, 101:1792-1798.
2. Bakir S., Mori T., Durand J., et al. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 2000, 101:2342-2344.
3. McDonnell D.P. The molecular pharmacology of SERMs. Trends Endocrinol Metab 1999, 10:301-311.
4. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
5. Green S., Walter P., Kumar V., et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320:134-139.
6. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994, 89:1943-1950.
7. Colburn P., Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978, 201:817-819.
8. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
9. Weiner C.P., Lizasoain I., Baylis S.A., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994, 91:5212-5216.
10. Liang M., Ekblad E., Lydrup M.L., et al. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression. Cell Tissue Res 2003, 313:63-70.
11. Zhu Y., Bian Z., Lu P., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002, 295:505-508.
12. Domingues-Montanari S., Subirana I., Tomas M., et al. Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem 2008, 54:1183-1189.
13. Rexrode K.M., Ridker P.M., Hegener H.H., et al. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 2007, 53:1749-1756.
14. Mansur Ade P., Nogueira C.C., Strunz C.M., et al. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res 2005, 36:511-517.
15. Ogawa S., Emi M., Shiraki M., et al. Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure. J Hum Genet 2000, 45:327-330.
16. Ashraf M.S., Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Rep 2006, 8:368-376.
17. Lubianca J.N., Moreira L.B., Gus M., et al. Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension. J Hum Hypertens 2005, 19:451-455.
18. Lubianca J.N., Faccin C.S., Fuchs F.D. Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. Contraception 2003, 67:19-24.
19. Li Y., Zhou L., Coulter D., et al. Prospective cohort study of the association between use of low-dose oral contraceptives and stroke in Chinese women. Pharmacoepidemiol Drug Saf 2006, 15:726-734.
20. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446.
21. Alessio A.M., Hoehr N.F., Siqueira L.H., et al. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb Res 2007, 120:639-645.
22. Curtis K.M., Mohllajee A.P., Martins S.L., et al. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception 2006, 73:179-188.
23. Baillargeon J.P., McClish D.K., Essah P.A., et al. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005, 90:3863-3870.
24. Chasan-Taber L., Willett W.C., Manson J.E., et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996, 94:483-489.
25. Duan J., Wainwright M.S., Comeron J.M., et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 12:205-216.